Home
New Enterprise Associates 17 reported a 7.9% stake in Monte Rosa Therapeutics GLUE · 6,692,298 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 7.9%
- Last report
- 9.7% · filed 26/03/19
- Shares held
- 6,692,298 sh
- Class
- Common Stock, par value $0.0001 per share
- Event date
- 26/07/01
- Filed
- 26/07/06
7.9% stake · −1.8pp from the last report
- Stake
- 7.9%
- Last report
- 9.7%
- Since last report
- −1.8pp
Monte Rosa Therapeutics trades, last 26 weeks
What else happened in Monte Rosa Therapeutics around then
Filed or reported within 30 days of the trade day · 06/01~07/31New Enterprise Associates 17's other 5% stake reports
- New Enterprise Associates 17
5% stakeInventiva
5% stakeInventiva
IVA
4.9% stake
9,372,390 sh
4.9% stake
Filed 04/01
- New Enterprise Associates 17
5% stakeMonte Rosa Therapeutics
5% stakeMonte Rosa Therapeutics
GLUE
9.7% stake
7,797,030 sh
9.7% stake
Filed 03/19
- New Enterprise Associates 17
5% stakeKorro Bio
5% stakeKorro Bio
KRRO
9.9% stake
1,456,677 sh
9.9% stake
Filed 03/12
- New Enterprise Associates 17
5% stakeSpyGlass Pharma
5% stakeSpyGlass Pharma
SGP
22.2% stake
7,393,823 sh
22.2% stake
Filed 02/13
- New Enterprise Associates 17
5% stakeMBX Biosciences
5% stakeMBX Biosciences
MBX
8.1% stake
3,619,474 sh
8.1% stake
Filed 25/11/10
